COVID-19 Screening
Self-Administered Viral Marker Test
HireRight’s U.S.-based COVID-19 screening solution offers simple, self-administered viral marker* tests that can be performed in the safety and security of an employee's home. The test detects the presence of coronavirus in a saliva sample that is easy to collect and is not "technique dependent".
How It Works
Test kits will be sent directly to the employee's preferred location. The employee will complete a short online questionnaire and self-administer the test (simple saliva test). Once completed, the specimen is mailed to the accredited lab in provided postage-paid packaging. Final test results provided by the lab will be reported to both the employee and the employer.
COVID-19 Screening
As the country returns to work, employers need to consider how best to decrease the possible spread of COVID-19 and lower the potential impact to their workforce. Until a vaccine is available, COVID-19 screening provides employers with an additional tool to help them in their decisions to reopen their businesses while striving to reduce the risk to their employees and customers of COVID-19 exposure.
- Self-administered test performed from the comfort of the employee's home
- Easier and less invasive to administer than clinic tests
- Helps minimize the risk of mass absenteeism due to contagion spread
- May mitigate the reputational risk of pandemic-related disruptions
- Testing may provide additional data for employers to consider when making return to work decisions
Key Features
- Convenient batch ordering available for large volumes of employee tests
- Individual kits can be sent in bulk to the employer for distribution or sent directly to the employee
- Collection kit includes sample collection device, instructions, and pre-paid packaging to send to the lab
- Optional counseling from physician available for employees testing positive
- Results performed by an accredited laboratory
- Test results placed in HireRight system for review
*Testing Disclosure: This viral marker test (molecular via RT-PCR) has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by Clinical Reference Laboratory, Inc. located in Lenexa, KS. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3 (b)(1), unless the authorization is terminated or revoked sooner.